We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+0.61%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$8.15B
AUM Growth
+$921M
(+13%)
Cap. Flow
+$973M
Cap. Flow
% of AUM
11.94%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
1,064
New
127
Increased
460
Reduced
259
Closed
156
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$86.3M |
| 2 |
DuPont de Nemours
DD
|
+$57.9M |
| 3 |
Microsoft
MSFT
|
+$49.7M |
| 4 |
Gilead Sciences
GILD
|
+$47.8M |
| 5 |
Ford
F
|
+$39.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$71M |
| 2 |
TJX Companies
TJX
|
+$53.3M |
| 3 |
Intuit
INTU
|
+$38.1M |
| 4 |
Costco
COST
|
+$34.3M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$17.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.42% |
| 2 | Financials | 17.1% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Healthcare | 12.19% |
| 5 | Industrials | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Ardelyx
ARDX
$1.24B
| $387K | ﹤0.01% |
82,260
+45,051
| +121% | +$156K |
|
|
CLVS
752
DELISTED
Clovis Oncology, Inc.
CLVS
| $386K | ﹤0.01% |
98,250
+85,000
| +642% | +$688K |
|
753
Domo
DOMO
$166M
| $379K | ﹤0.01% |
+23,700
| New | +$572K |
|
|
HONE
754
DELISTED
HarborOne Bancorp
HONE
| $379K | ﹤0.01% |
37,608
+3
| +0% | +$31 |
|
|
ALEX
755
DELISTED
Alexander & Baldwin
ALEX
| $377K | ﹤0.01% |
15,393
-24,238
| -61% | -$569K |
|
756
Texas Capital Bancshares
TCBI
$4.31B
| $377K | ﹤0.01% |
6,890
| – | – |
|
757
Flex
FLEX
$43.4B
| $364K | ﹤0.01% |
+46,180
| New | +$355K |
|
758
Aquestive Therapeutics
AQST
$462M
| $363K | ﹤0.01% |
114,211
+28,315
| +33% | +$106K |
|
|
ECHO
759
EchoStar
ECHO
$25.5B
| $361K | ﹤0.01% |
9,100
-2,993
| -25% | -$108K |
|
|
NSA
760
DELISTED
National Storage Affiliates Trust
NSA
| $358K | ﹤0.01% |
10,720
+1,840
| +21% | +$58.2K |
|
761
Rhythm Pharmaceuticals
RYTM
$7B
| $352K | ﹤0.01% |
+16,318
| New | +$350K |
|
|
IVAC
762
DELISTED
Intevac Inc
IVAC
| $352K | ﹤0.01% |
67,260
-31,166
| -32% | -$155K |
|
763
Ecovyst
ECVT
$1.36B
| $346K | ﹤0.01% |
21,680
-2,980
| -12% | -$45.6K |
|
764
James River Group Holdings
JRVR
$218M
| $345K | ﹤0.01% |
+6,742
| New | +$329K |
|
|
EMKR
765
DELISTED
Emcore Corp
EMKR
| $345K | ﹤0.01% |
11,249
-1,977
| -15% | -$59K |
|
|
FBMS
766
DELISTED
The First Bancshares, Inc.
FBMS
| $344K | ﹤0.01% |
10,652
-856
| -7% | -$27.2K |
|
|
AGTC
767
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $344K | ﹤0.01% |
82,624
+1,000
| +1% | +$3.61K |
|
|
PCTI
768
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $326K | ﹤0.01% |
38,782
+3,100
| +9% | +$18.4K |
|
769
VYNE Therapeutics
VYNE
$340K
| $324K | ﹤0.01% |
20
-12
| -38% | -$194K |
|
770
Forestar Group
FOR
$1.44B
| $319K | ﹤0.01% |
17,425
| – | – |
|
|
BHR
771
Braemar Hotels & Resorts
BHR
$153M
| $318K | ﹤0.01% |
34,237
+3,838
| +13% | +$34.8K |
|
772
Kinsale Capital Group
KNSL
$7.95B
| $318K | ﹤0.01% |
3,080
-1,160
| -27% | -$111K |
|
773
Home Bancorp
HBCP
$552M
| $316K | ﹤0.01% |
8,116
| – | – |
|
774
Fossil Group
FOSL
$239M
| $311K | ﹤0.01% |
24,900
-27,300
| -52% | -$309K |
|
775
Minerva Neurosciences
NERV
$188M
| $299K | ﹤0.01% |
4,823
-18,216
| -79% | -$1.03M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2019 Portfolio in Review
As of Q3 2019, Jacobs Levy Equity Management held 1,064 positions worth $8.15B, up 13% from $7.23B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Jacobs Levy Equity Management deployed $973M of net new capital in Q3 2019, opening 127 new positions and adding to 460 existing holdings. Its largest new stake was Qualcomm: 1,146,127 shares worth $87.4M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Boeing, an estimated $71M trimmed.
- Jacobs Levy Equity Management's largest Q3 2019 buy was Qualcomm: 1,146,127 shares worth $87.4M.
- Jacobs Levy Equity Management added most to DuPont de Nemours in Q3 2019, an estimated $57.9M increase.
- Jacobs Levy Equity Management's biggest Q3 2019 reduction was Boeing, cutting an estimated $71M.
- Jacobs Levy Equity Management fully exited TJX Companies in Q3 2019, selling an estimated $53.3M.
- Jacobs Levy Equity Management's ten largest holdings make up 16% of its $8.15B portfolio in Q3 2019.
- Jacobs Levy Equity Management opened 127 new positions and closed 156 in Q3 2019.
- Jacobs Levy Equity Management's portfolio value rose 13% quarter-over-quarter to $8.15B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2019, filed 14 Nov 2019.